1 Measles Fact Sheet 1. What is measles? – Measles is an acute
... months of age. The second dose of MMR or MMRV is routinely given at ages 4 to 6 years of age, before the child enters Kindergarten or first grade. . 7. What do I do if I know I have been exposed? - People exposed to someone who has measles should consult their health care provider immediately. If t ...
... months of age. The second dose of MMR or MMRV is routinely given at ages 4 to 6 years of age, before the child enters Kindergarten or first grade. . 7. What do I do if I know I have been exposed? - People exposed to someone who has measles should consult their health care provider immediately. If t ...
Document
... infection (LTBI) using tuberculin skin test (TST). Infected persons who do not present with symptoms of TB are not infectious. However, they are at risk of developing active TB disease and becoming infectious. The lifetime risk of reactivation TB for a person with documented LTBI is estimated to be ...
... infection (LTBI) using tuberculin skin test (TST). Infected persons who do not present with symptoms of TB are not infectious. However, they are at risk of developing active TB disease and becoming infectious. The lifetime risk of reactivation TB for a person with documented LTBI is estimated to be ...
Full-Text PDF
... Neuman et al., review enumerating membrane rearrangements from many (+) RNA viruses [15], as well as in this issue [16]. Our review focuses on the major role that electron microscopy has played in elucidating the extensive protein-lipid structures that are induced to support replication of the picor ...
... Neuman et al., review enumerating membrane rearrangements from many (+) RNA viruses [15], as well as in this issue [16]. Our review focuses on the major role that electron microscopy has played in elucidating the extensive protein-lipid structures that are induced to support replication of the picor ...
4.3 Haemophilus influenzae type b
... can be provided as either the monovalent Hib vaccine or the combination vaccine Hib-MenCCV (refer to 4.10 Meningococcal disease). Children aged >15 months and up to 59 months of age at presentation who have not received a primary course of a Hib or Hib-containing vaccine will only require 1 dose of ...
... can be provided as either the monovalent Hib vaccine or the combination vaccine Hib-MenCCV (refer to 4.10 Meningococcal disease). Children aged >15 months and up to 59 months of age at presentation who have not received a primary course of a Hib or Hib-containing vaccine will only require 1 dose of ...
Mumps FAQs
... Q: What is the current mumps situation in Ireland? A: Since early November 2004 there has been an increase in mumps cases among teenagers and young adults. This is more than double the number reported for the first 10 months of 2004. The cases appear to be occurring mainly in individuals who were ne ...
... Q: What is the current mumps situation in Ireland? A: Since early November 2004 there has been an increase in mumps cases among teenagers and young adults. This is more than double the number reported for the first 10 months of 2004. The cases appear to be occurring mainly in individuals who were ne ...
Precautions for Varicella Vaccine
... The inactivated influenza vaccine (IIV) or influenza live, attenuated virus vaccine (ILAVV) may be given annually to all consenting individuals 6 years of age and older in whom the vaccine is not contraindicated. Priority will be given to high-risk populations during years of vaccine shortage and as ...
... The inactivated influenza vaccine (IIV) or influenza live, attenuated virus vaccine (ILAVV) may be given annually to all consenting individuals 6 years of age and older in whom the vaccine is not contraindicated. Priority will be given to high-risk populations during years of vaccine shortage and as ...
Immunization
... cause no symptoms at all, affected individuals can exhibit a range of symptoms if the virus enters the blood stream.[3] In about 1% of cases, the virus enters the central nervous system, preferentially infecting and destroying motor neurons, leading to muscle weakness and acute flaccid paralysis ...
... cause no symptoms at all, affected individuals can exhibit a range of symptoms if the virus enters the blood stream.[3] In about 1% of cases, the virus enters the central nervous system, preferentially infecting and destroying motor neurons, leading to muscle weakness and acute flaccid paralysis ...
Information regarding the Mumps Virus (Word)
... How is mumps spread? Mumps is transmitted by direct contact with saliva produced in the mouth and discharges from the nose and throat of infected individuals. Mumps can also be spread by sharing food or beverages with an infected person. Classroom contact and shared dining spaces are considered limi ...
... How is mumps spread? Mumps is transmitted by direct contact with saliva produced in the mouth and discharges from the nose and throat of infected individuals. Mumps can also be spread by sharing food or beverages with an infected person. Classroom contact and shared dining spaces are considered limi ...
Immunization 5
... Should be protected from light and needs to be used within 30 minutes of its reconstitution May be given with all other childhood vaccines Recommendation: two doses of varicella vaccine given at the age of 15 months & second dose at 4-6 years VZIg: for individuals with significant contact with varic ...
... Should be protected from light and needs to be used within 30 minutes of its reconstitution May be given with all other childhood vaccines Recommendation: two doses of varicella vaccine given at the age of 15 months & second dose at 4-6 years VZIg: for individuals with significant contact with varic ...
Week 45, 6-12 November 2016 CDTR - ECDC
... Measles is a highly infectious disease and frequently results in widespread outbreaks, mainly among unvaccinated individuals. Measles can be complicated by pneumonia, otitis media, laryngotracheo-bronchitis; and diarrhoea occurs commonly in young children. Case-fatality rates increase in children yo ...
... Measles is a highly infectious disease and frequently results in widespread outbreaks, mainly among unvaccinated individuals. Measles can be complicated by pneumonia, otitis media, laryngotracheo-bronchitis; and diarrhoea occurs commonly in young children. Case-fatality rates increase in children yo ...
Flu Facts
... complications or because they live with or care for high risk persons. During flu seasons when vaccine supplies are limited or delayed, the Advisory Committee on Immunization Practices (ACIP) makes recommendations regarding priority groups for vaccination. Please visit www.cdc.gov/flu for more infor ...
... complications or because they live with or care for high risk persons. During flu seasons when vaccine supplies are limited or delayed, the Advisory Committee on Immunization Practices (ACIP) makes recommendations regarding priority groups for vaccination. Please visit www.cdc.gov/flu for more infor ...
Recommendations of the Advisory Committee on Immunization Practices (ACIP):
... B. HIV-Infected Persons In general, persons known to be HIV infected should not receive live-virus or livebacteria vaccines. However, evaluation and testing for HIV infection of asymptomatic persons are not necessary before decisions concerning vaccination with live-virus vaccines are made. Limited ...
... B. HIV-Infected Persons In general, persons known to be HIV infected should not receive live-virus or livebacteria vaccines. However, evaluation and testing for HIV infection of asymptomatic persons are not necessary before decisions concerning vaccination with live-virus vaccines are made. Limited ...
vaccines for life - Irish Pharmaceutical Healthcare Association
... However, a personal choice not to vaccinate has a wider public impact. Not only is it a decision that may put one’s own life, and that of one’s child, at risk, but it also puts those who come into contact with an unvaccinated person at risk. Such contact is particularly dangerous for people with a r ...
... However, a personal choice not to vaccinate has a wider public impact. Not only is it a decision that may put one’s own life, and that of one’s child, at risk, but it also puts those who come into contact with an unvaccinated person at risk. Such contact is particularly dangerous for people with a r ...
Application APP202377 - Environmental Protection Authority
... egg production and quality. In IBV-infected flocks, the morbidity rate (disease incidence) can reach 100%, but the mortality rate depends on factors including the virulence of the strain, presence of secondary infections, flock age, immune status, management and environmental factors (Awad et al, ...
... egg production and quality. In IBV-infected flocks, the morbidity rate (disease incidence) can reach 100%, but the mortality rate depends on factors including the virulence of the strain, presence of secondary infections, flock age, immune status, management and environmental factors (Awad et al, ...
Influenza Vaccination of Healthcare Workers and Vaccine Allocation
... in large studies specifically targeting HCWs (Fig. 1).35-39 Influenza vaccination reduces influenza infection in HCWs by 88%39 and decreases work absence due to respiratory illness by 28%.38 In two separate studies in geriatric long-term–care facilities, total patient mortality was significantly lower i ...
... in large studies specifically targeting HCWs (Fig. 1).35-39 Influenza vaccination reduces influenza infection in HCWs by 88%39 and decreases work absence due to respiratory illness by 28%.38 In two separate studies in geriatric long-term–care facilities, total patient mortality was significantly lower i ...
Disease Fact Sheet Mumps
... (located just below the front of the ear). Approximately one-third of infected people do not exhibit symptoms. How soon after infection do symptoms occur? The incubation period is usually 16 to 18 days, although it may vary from 14 to 25 days. What complications have been associated with mumps? Mump ...
... (located just below the front of the ear). Approximately one-third of infected people do not exhibit symptoms. How soon after infection do symptoms occur? The incubation period is usually 16 to 18 days, although it may vary from 14 to 25 days. What complications have been associated with mumps? Mump ...
PDF 250 KB - Parliament of Victoria
... especially government acknowledged serious adverse effects of vaccines and their frequencies, and the impact it would have upon inalienable human rights. 2. Summary of key points The Bill’s stated purpose is “to increase immunisation rates for young children in the community.” In seeking to argue fo ...
... especially government acknowledged serious adverse effects of vaccines and their frequencies, and the impact it would have upon inalienable human rights. 2. Summary of key points The Bill’s stated purpose is “to increase immunisation rates for young children in the community.” In seeking to argue fo ...
Flu Facts
... complications or because they live with or care for high risk persons. During flu seasons when vaccine supplies are limited or delayed, the Advisory Committee on Immunization Practices (ACIP) makes recommendations regarding priority groups for vaccination. Please visit www.cdc.gov/flu for more infor ...
... complications or because they live with or care for high risk persons. During flu seasons when vaccine supplies are limited or delayed, the Advisory Committee on Immunization Practices (ACIP) makes recommendations regarding priority groups for vaccination. Please visit www.cdc.gov/flu for more infor ...
Neurologic adverse events following vaccination
... 2. unrelated to the immune system - patients whose postvaccinal reactions may be related to the toxic effects of the vaccine components or may result from the vaccine virus turning virulent, resulting in complete or abortive symptoms of the disease. Another classification of adverse events following ...
... 2. unrelated to the immune system - patients whose postvaccinal reactions may be related to the toxic effects of the vaccine components or may result from the vaccine virus turning virulent, resulting in complete or abortive symptoms of the disease. Another classification of adverse events following ...
Vaccine Developing Countries Vaccine Manufacturers Network
... spread of hepatitis E around the world. With advice from international organizations to introduce the vaccine where needed, initial introduction may focus on high-risk populations, such as women of child-bearing age, chronic liver disease patients, and food industry workers. Xiamen Innovax, a member ...
... spread of hepatitis E around the world. With advice from international organizations to introduce the vaccine where needed, initial introduction may focus on high-risk populations, such as women of child-bearing age, chronic liver disease patients, and food industry workers. Xiamen Innovax, a member ...
Characterization of outbreak response strategies and potential vaccine stockpile
... use at least one IPV RI dose (i.e., IPV5). cVDPV outbreaks occur deterministically in the model depending on population immunity at and beyond OPV cessation, but all other potential poliovirus reintroductions (from iVDPVs, IPV productions sites, inadvertent OPV use, or other unintentional or intenti ...
... use at least one IPV RI dose (i.e., IPV5). cVDPV outbreaks occur deterministically in the model depending on population immunity at and beyond OPV cessation, but all other potential poliovirus reintroductions (from iVDPVs, IPV productions sites, inadvertent OPV use, or other unintentional or intenti ...
Epidemiology of Measles
... In contrast, in third world countries, measles infection has its greatest incidence in children under 2 years of age. the disease is a serious problem with a high mortality (10%) with malnutrition being an important factor in developing countries ...
... In contrast, in third world countries, measles infection has its greatest incidence in children under 2 years of age. the disease is a serious problem with a high mortality (10%) with malnutrition being an important factor in developing countries ...
Addressing Parents` Concerns: Do Multiple Vaccines
... the immune response would be to estimate the number of vaccines to which a child could respond at one time. If we assume that 1) approximately 10 ng/mL of antibody is likely to be an effective concentration of antibody per epitope (an immunologically distinct region of a protein or polysaccharide),3 ...
... the immune response would be to estimate the number of vaccines to which a child could respond at one time. If we assume that 1) approximately 10 ng/mL of antibody is likely to be an effective concentration of antibody per epitope (an immunologically distinct region of a protein or polysaccharide),3 ...
Vaccine Epidemiology - Hospital Industry Data Institute
... vaccination. A monovalent rotavirus vaccine is also licensed for use in the United States [2, 3] but was not available during the study period. The Curns et al [6] study is timely and important and also highlights the distinction between the epidemiologic concepts of vaccine efficacy and vaccine eff ...
... vaccination. A monovalent rotavirus vaccine is also licensed for use in the United States [2, 3] but was not available during the study period. The Curns et al [6] study is timely and important and also highlights the distinction between the epidemiologic concepts of vaccine efficacy and vaccine eff ...
FOR HKMA CME MEMBER USE ONLY. DO NOT REPRODUCE OR...
... Objective: To characterize the causes and treatment of facial nerve paresis (FNP) in pediatric patients. Method: Retrospective study in a tertiary care pediatric hospital. Thirty-four patients identified with partial or complete FNP evaluated between 1997 and 2003. A review of the medical records in ...
... Objective: To characterize the causes and treatment of facial nerve paresis (FNP) in pediatric patients. Method: Retrospective study in a tertiary care pediatric hospital. Thirty-four patients identified with partial or complete FNP evaluated between 1997 and 2003. A review of the medical records in ...
Poliomyelitis
Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as: fever, headache, vomiting, diarrhea, neck stiffness and pains in the arms and legs. These people are usually back to normal within one or two weeks. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to few days. The weakness most often involves the legs but may less commonly involve the muscles of the head, neck and diaphragm. Many but not all people fully recover. In those with muscle weakness about 2% to 5% of children and 15% to 30% of adults die. Years after recovery post-polio syndrome may occur, with a slow development of muscle weakness similar to what the person had during the initial infection.Poliovirus is usually spread from person to person through infected feces entering the mouth. It may also be spread by food or water containing human feces and less commonly from infected saliva. Those who are infected may spread the disease even if no symptoms are present for up to six weeks. The disease may be diagnosed by finding the virus in the feces or detecting antibodies against it in the blood.The disease is preventable with the polio vaccine; however, a number of doses are required for it to be effective. The United States Center for Disease Control recommends polio vaccination boosters for travelers and those who live in countries where the disease is occurring. Once infected there is no specific treatment. In 2013 polio affected 416 people down from 350,000 cases in 1988. In 2014 the disease was only spreading between people in Afghanistan, Nigeria, and Pakistan. In 2015 wild polio was eliminated in Nigeria.Poliomyelitis has existed for thousands of years, with depictions of the disease in ancient art. The disease was first recognized as a distinct condition by Michael Underwood in 1789 and the virus that causes it was first identified in 1908 by Karl Landsteiner. Major outbreaks started to occur in the late 19th century in Europe and the United States. In the 20th century it became one of the most worrying childhood diseases in these areas. The first polio vaccine was developed in the 1950s by Jonas Salk. It is hoped that vaccination efforts and early detection of cases will result in global eradication of the disease by 2018. In 2013; however, there were reports of new cases in Syria and in May 2014, the World Health Organization declared a public health emergency of international concern due to outbreaks of the disease in Asia, Africa and the Middle East. The disease does not naturally occur in any other animals.